Achieve Life Sciences Stockholders Consider Board Slate and Share Increase at Annual Meeting
At its 2026 annual meeting, Achieve Life Sciences presented a slate of nine directors for election and proposed doubling the number of authorized common shares from 150 million to 300 million. The move aims to provide greater flexibility for future financing or corporate actions.
Tickers: $ACHV
Topics: board election share authorization increase stockholder vote